Herpesvirus hominis Type 2 Infections in Rabbits: Effect of Prior Immunization with Attenuated Mycobacterium bovis (BCG) Cells
AUTOR(ES)
Larson, C. L.
RESUMO
Angora, New Zealand, and Dutch-belted rabbits were tested for their susceptibility to graded doses of Herpesvirus hominis type 2 administered by vaginal instillation, intracorneal injection, and scarification of the cornea. Central nervous system involvement and death occurred after infection by the various routes employed. Prior immunization of Dutch-belted and New Zealand rabbits with viable Mycobacterium bovis (BCG) cells injected intravenously provided protection against subsequent infections with type 2 virus.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=422560Documentos Relacionados
- Susceptibility of Rabbits Immunized with Mycobacterium bovis (BCG) or Mycobacterium phlei to Shigella Keratoconjunctivitis
- Paucibacillary Tuberculosis in Mice after Prior Aerosol Immunization with Mycobacterium bovis BCG
- Virulence of Six Strains of Mycobacterium bovis (BCG) in Mice
- Resistance of Female Mice to Vaginal Infection Induced by Herpesvirus hominis Type 2: Effects of Immunization with Mycobacterium bovis, Intravenous Injection of Specific Herpesvirus hominis Type 2 Antiserum, and a Combination of These Procedures
- Growth of mycobacterium bovis (BCG) in T lymphocyte-depleted mice.
